Pharma FDI In India Doubled In First Fiscal Quarter Over Last Year
This article was originally published in PharmAsia News
Foreign direct investment in India's pharmaceuticals sector reached $1 billion during the spring quarter of this year to lead all other industries, according to figures released by the Department of Industrial Policy and Promotion.
You may also be interested in...
A report from the US FDA says the agency will focus on updating its premarket submission portal, training staff and taking additional steps to start taking in applications for ASCA pilot participant sponsors.
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.